Sheila Nainan Myatra

Panelists discuss the dosing impacts of steroids in the COVID STEROID 2 trial, embracing Bayesian approaches in clinical trials for more nuanced interpretations, navigating complexities in trial interpretation beyond statistical significance, debating optimal dosage of dexamethasone in COVID-19 treatment, analyzing timing and effectiveness of corticosteroids in ARDS, and reflecting on the collaborative effort in advancing understanding of COVID-19 treatment.